| Source: |
| Type: |
| Antipyretic Activity Alternative Names: Antipyretic Effect, Fever-Reducing Activity Type: Therapeutic effect / functional outcome / thermoregulatory outcome Function: Antipyretic activity describes the ability of a compound, treatment, or biological intervention to reduce an abnormally elevated body temperature caused by fever, generally by modulating inflammatory and hypothalamic thermoregulatory pathways. Favorable Direction: ↑ Antipyretic activity is favorable and corresponds to ↓ fever-associated body temperature toward the normal physiological range. Mechanisms: Antipyretic effects commonly involve reduced production or signaling of pyrogenic mediators such as prostaglandin E2 (PGE2), COX-2, IL-1β, IL-6, and TNF-α, particularly within pathways that influence the hypothalamic temperature set point. Interpretation Note: Antipyretic activity refers specifically to reduction of fever and should be distinguished from nonspecific hypothermia. A treatment that lowers normal body temperature is not necessarily demonstrating a desirable antipyretic effect. |
| 8434- | OM, | Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1833 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid